Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06351020
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2024-03-15
Brief Title:
LM-302 for the Treatment of Subjects With Claudin182-Positive Gastric and Gastroesophageal Junction Adenocarcinoma
Sponsor:
LaNova Medicines Zhejiang Co Ltd
Organization:
LaNova Medicines Limited
Organization Data
Organization:
LaNova Medicines Limited
Class:
INDUSTRY
Study ID:
LM302-03-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
LaNova Medicines Zhejiang Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None